Different combinations of salts affect the growth and bacteriocin production by Lactobacillus salivarius CRL 1328
BACKGROUND: The culture medium for optimal growth of vaginal Lactobacillus salivarius CRL 1328 is different from that for optimal bacteriocin production. To simultaneously obtain high amount of biomass and bacteriocin of this microorganism, the effects of different basal culture media and salts on b...
Gespeichert in:
Veröffentlicht in: | Journal of chemical technology and biotechnology (1986) 2010, Vol.85 (1), p.91-99 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND: The culture medium for optimal growth of vaginal Lactobacillus salivarius CRL 1328 is different from that for optimal bacteriocin production. To simultaneously obtain high amount of biomass and bacteriocin of this microorganism, the effects of different basal culture media and salts on both responses were evaluated. The study was performed by using a complete factorial experimental design 2⁶, with central points. Sixty-four different growth media, which resulted from the combinations of two basal culture media and two concentrations of five salts (ammonium citrate, sodium acetate, MgSO₄, MnSO₄, and K₂HPO₄) were assayed.RESULTS: Only the addition of MnSO₄ to each culture medium significantly stimulated the growth of L. salivarius. The presence of sodium acetate or MgSO₄ stimulated the bacteriocin production, while MnSO₄ and K₂HPO₄ exerted an inhibitory effect. However, the simultaneous addition of MnSO₄ and sodium acetate to both basal culture media allowed high bacteriocin levels to be reached, attenuating the inhibitory effect of Mn²⁺.CONCLUSIONS: The application of a complete experimental design contributed to simultaneous optimization of the biomass and bacteriocin production of L. salivarius CRL 1328. The results obtained are potentially applicable to the technological production of probiotic bacteria and antagonistic substance to be included in a probiotic pharmaceutical product. Copyright |
---|---|
ISSN: | 0268-2575 1097-4660 1097-4660 |
DOI: | 10.1002/jctb.2271 |